Category - Latest Science

GHP News Latest Science

Cost-effectiveness of infant and maternal RSV immunization strategies, in British Columbia, Canada

Critical Summary This article evaluates the cost-effectiveness of recently available respiratory syncytial virus (RSV) immunization options—nirsevimab (a long-acting monoclonal antibody) and the maternal RSVpreF...

4 December, 2025

4 min read

GHP News Latest Science

Safety and Immunogenicity of an rVSV Lassa fever vaccine candidate

Critical Summary The article by Malkin et al. presents the results of a phase 1, double-blind, randomized clinical trial evaluating the safety and immunogenicity of the rVSVΔG-LASV-GPC vaccine, a recombinant vesicular...

3 December, 2025

4 min read

GHP News Latest Science

The relationship between immunogenicity and reactogenicity of vaccines

This narrative review by Gromer et al. provides a comprehensive synthesis of the long-observed but poorly characterized relationship between vaccine reactogenicity—short-term, inflammatory adverse events—and...

3 December, 2025

4 min read

GHP News Latest Science

Active surveillance for emerging influenza A viruses – findings from a one health study in Vietnam’s live bird markets

The 2025 study by Bui and colleagues reports on active, periodic surveillance of influenza A viruses (AIVs) at live bird markets (LBMs) in northern Vietnam — a region and context recognized as high-risk for zoonotic...

3 December, 2025

7 min read

GHP News Latest Science

December 1, 2025: Current infectious disease outbreaks

Marburg virus disease – Ethiopia (first recorded national outbreak) Marburg is a filovirus causing severe hemorrhagic fever with high case fatality; Ethiopia’s first outbreak in South Ethiopia Region has led to multiple...

3 December, 2025

5 min read

GHP News Latest Science

Longitudinal trends in the endemic symptomatic burden of COVID-19: Insights from community-based participatory virological surveillance in the Netherlands, November 2020 – April 2025

This article presents a large-scale, longitudinal analysis of symptom patterns and the perceived disease burden of COVID-19 in the Netherlands, covering a 4.5-year period from November 2020 to April 2025. Using data...

3 December, 2025

4 min read

GHP News Latest Science

On the way back: New US vaccines and vaccination policy

Health Secretary Kennedy’s new policy direction on vaccines centers on undermining CDC assurances about vaccine safety (especially regarding autism and aluminum adjuvants) and on opening the door to schedule changes...

3 December, 2025

4 min read

GHP News Latest Science

The art of ending – how to best eradicate polio

As one of the most prominent expert on polio, Jacob John and his colleagues write, vaccine safety is usually defined as the absence of serious adverse events in the vaccine recipient, yet the continued use of oral...

26 November, 2025

2 min read

GHP News Latest Science

Update on Lyme diseases vaccine

The first modern Lyme vaccine, LYMErix, was an OspA-based recombinant subunit vaccine that showed good efficacy and acceptable safety in phase III trials but ultimately failed due to a confluence of scientific...

26 November, 2025

9 min read

GHP News Latest Science

The American CDC on vaccines and autism

For many years, the CDC’s vaccine-safety pages stated clearly that vaccines do not cause autism and used that phrase as a concise summary of a large evidence base. The earlier material explained that multiple large...

26 November, 2025

6 min read